This exceptional investment and networking event – recognized by the medical device industry as the leading medical technology investment forum in Europe – is taking place April 25th through 27th, 2017, at the historic and centrally located Shelbourne Hotel, Dublin, overlooking St. Stephen’s Green. The two-and-a-half-day forum will feature presentations by 40+ early-stage medical device companies from around the world, along with thought-leading guest speakers, on-stage interviews with key device executives and VCs, and insightful and timely panel discussions, all providing candid insight on topics of utmost importance to all stakeholders in the rapidly evolving global device marketplace. Our event will also feature the popular and exciting MedTech Innovator start-up competition, hosted by Paul Grand, CEO.
Don't miss Medical Alley's premier annual gathering – about you, for you! Reconnect with the colleagues and industry leaders that make Medical Alley the global epicenter of health technology and care. Celebrate our leadership, innovation and impact on improving and saving lives.
We'll deliver insights into the current state of Medical Alley, outline projections for 2017 and provide great content and comradery. Medical Alley IS powering the evolution of healthcare.
Watch it live:
Wednesdays in May: May 3rd, 10, 17, & 24
11:00 am–1:00 pm EDT
Or view on demand
The European Commission published proposals for new regulations of medical devices and in vitro diagnostics in 2012. Now, after years of negotiation within the EU legislative system and with interested stakeholders, the new regulations are expected to be published in 2017. This four-week virtual program draws together industry experts and leading Notified Bodies who have been closely following the evolution of the proposed regulations, anticipating the final texts, developing positions on what will be required by the regulations, and understanding the impact on manufacturers, devices and systems both new and legacy.
Uniquely, each week provides different perspectives/opinions from different Notified Bodies and experts on the key significant changes that will impact all medical devices and in vitro diagnostics being placed into Europe under the new European Medical Device Regulation (MDR) and the In VitroDiagnostics Regulation (IVDR). This program will also consider the impact on legacy devices cleared, CE marked, and under the existing EU Medical Device Directive (MDD) and In Vitro Diagnostics Directive (IVDD).
From the convenience of your own viewing location, this cost-effective resource is one you can watch live with your colleagues. Recordings of the sessions will also be available with your registration.
Learn how to navigate the complex world of Bioventures in this rigorous program for business leaders. Through a blend of lecture-based learning and interactive case discussions, you will develop a deeper understanding of clinical problems, solution creation and early-stage product development in the context of regulatory and stakeholder requirements. Explore business opportunities as you gain competency in a wide range of key issues, including the methodology of strategic clinical problem-solving and core elements of early product development. You’ll also learn to identify, assess and address ethical issues associated with innovating clinical technologies.
Featuring a lecture-based format with interactive case study discussions, this program serves as a guide to the later stages of product development in the life sciences division. You will learn how to create a compelling value proposition and how to approach regulatory compliance, marketing, capital acquisition and integrated product-launch models. You’ll also study clinical trial requirements, regulatory strategy and compliance, integrated product launch strategies, competitive advantage analysis and business plan development. To provide real-world context, experienced professionals will share firsthand accounts about navigating this process.
Minnesota’s Medical Alley continues to experience unprecedented investment in emerging health technology companies that has piqued interest from investors around the world. The MedTech Strategist, a key information and investment conferences provider serving the global medical technology industry, has produced two of the world’s most successful events for investors and emerging companies, with summits in Dublin, Ireland and San Francisco, as well as a well-respected publication providing essential, impactful device industry perspective and insight. The MedTech Strategist and the Medical Alley Association are proud to announce a partnership to co-host "The Medical Alley Innovation Summit Minneapolis 2017."
This Summit provides a forum for innovative emerging medical technology companies seeking investment, joint venture or other relationships to gain exposure to venture capital, investment bankers and large medical device companies for the purpose of potential investment and/or strategic partnership. It is organized as a two-day business partnering and networking event, featuring 40 pre-screened start-up medical technology companies that will deliver 10-minute presentations, followed by meetings in private breakout rooms. The Summit will also feature thought-leading guest speakers, and plenary and panel sessions, all providing candid insight on topics of utmost importance to all stakeholders in the rapidly evolving global device marketplace.
The MedTech Conference is your opportunity to connect with thousands of medical technology professionals this September. Join us in San Jose for business development, innovative technology, and networking with policymakers, business executives and industry leaders.